NYSE:GSK

Glaxosmithkline Stock News

Healthcare > Drug Manufacturers - General

Buy GSK

*Your capital is at risk

$51.46

-0.0700 (-0.136%)

At Close: Aug 05, 2026

GSK's speciality medicines arm gets the seal of approval from UK broker

09:26am, Wednesday, 12'th Feb 2025

Shore Capital has reiterated its ‘buy' rating on GSK PLC (LSE:GSK, NYSE:GSK), highlighting the strength of its speciality medicines business as the driving force behind future growth. Despite challe

GSK plc Class Action: Levi & Korsinsky Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSK

07:25am, Wednesday, 12'th Feb 2025

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow

GSK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

07:00am, Wednesday, 12'th Feb 2025

NEW YORK CITY, NY / ACCESS Newswire / February 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GS

GSK plc Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK

06:30pm, Tuesday, 11'th Feb 2025

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK

03:22pm, Tuesday, 11'th Feb 2025

NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc ("GSK" or the "Company") (NYSE: GSK). Such investors are advised to contact

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

03:00pm, Tuesday, 11'th Feb 2025

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Deposita

Deadline Approaching: GSK plc. (GSK) Investors Who Lost Money Urged To Contact Law Offices of Howard G.

12:27pm, Tuesday, 11'th Feb 2025

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming April 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who pur

Law Offices of Frank R. Cruz Encourages GSK plc.

12:10pm, Tuesday, 11'th Feb 2025

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class Action.

The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against GSK plc

11:00am, Tuesday, 11'th Feb 2025

LOS ANGELES, CA / ACCESS Newswire / February 11, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the C

GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

07:00am, Tuesday, 11'th Feb 2025

NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GS

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by